Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19

Clinical trial NCT05007522 · COMPLETED

Trial details

NCT number: NCT05007522
Sponsor: Sen-Jam Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Respiratory Infection

Start date: 2022-05-03
Primary completion: 2024-06-20
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.